The tariff classification of Carbidopa/Levodopa Tablets, Dexamethasone Tablets and Leuprolide Acetate Injection in dosage form, from India
Reasoning
The tariff classification of Carbidopa/Levodopa Tablets, Dexamethasone Tablets and Leuprolide Acetate Injection in dosage form, from India
Cite this ruling
CBP Ruling N325106 (3004909240): The tariff classification of Carbidopa/Levodopa Tablets, Dexamethasone Tablets and Leuprolide Acetate Injection in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Lastacaft™ eye drop in dosage form
The tariff classification of Famciclovir (CAS-104224-87-4) tablets imported in dosage form, from India.
The tariff classification of Topical Aerosol Skin Refrigerant
The tariff classification of Ethyl Chloride® Topical Anesthetic Skin Refrigerant
The tariff classification of Torsemide (CAS-56211-40-6) in dosage form, from India